Dermatitis: Clinical Trials

3 trials for Dermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 enrolling by invitation. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Enrolling by invitation 3

Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
IMG-007 - Atopic Dermatitis, Atopic Dermatitis Eczema
Phase 2Enrolling by invitationInmagene LLC4002026-06-052026-07-29
Efficacy of Topical Cannabidiol for Eczema
Cannabidiol (CBD), Triamcinolone (TAC) 0.1% cream - Chronic Pruritus, Eczema
Phase 2Enrolling by invitationKhon Kaen University602025-05-012026-08-04
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
JYP0061 15 mg, JYP0061 30 mg, Placebo - Moderate-to-severe Atopic Dermatitis
Phase 2Enrolling by invitationGuangzhou JOYO Pharma Co., Ltd1202023-12-272025-03-20

Narrower conditions

Dermatitis, Atopic (3)  ·  Eczema (2)  ·  Immune System Diseases (1)  ·  Skin Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Skin Diseases, Eczematous (3)  ·  Skin Diseases, Genetic (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Immune System Diseases (2)  ·  Skin Diseases (2)

Interventions

Cannabidiol (1)  ·  Triamcinolone (1)

Sponsors

Guangzhou JOYO Pharma Co., Ltd (1)  ·  Inmagene LLC (1)  ·  Khon Kaen University (1)

Countries

Canada (1)  ·  China (1)  ·  Thailand (1)  ·  United States (1)